Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer
Identificadores
Identificadores
Data de publicación
2013Título da revista
ANNALS OF ONCOLOGY
Tipo de contido
Artigo